![Kaouthar Lbiati](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kaouthar Lbiati
Directeur/Membre du Conseil chez
THERALASE TECHNOLOGIES INC.
Fortune : 41 906 $ au 31/05/2026
Profil
Kaouthar Lbiati is currently an Independent Director at Theralase Technologies, Inc. since 2023 and Vice President-Strategy & Corporate Development at Cytovia Therapeutics, Inc. Former positions include Chief Executive, Financial Officer & Director at Hepion Pharmaceuticals, Inc. from 2025 to 2026, Executive Director-Strategic Planning at Immune Pharmaceuticals, Inc., and Head-Strategy & Portfolio at Steba Biotech SA. Education includes graduate degrees from London School of Economics & Political Science and ESSEC Business School, and a doctorate from Mohammed V University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 20/05/2026 | 246 507 ( 0,1 % ) | 41 906 $ | 31/05/2026 | |
| 28/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Kaouthar Lbiati
| Sociétés | Poste | Début |
|---|---|---|
| THERALASE TECHNOLOGIES INC. | Directeur/Membre du Conseil | 06/06/2023 |
Cytovia Therapeutics, Inc.
 Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Develops immunotherapies for cancer and infectious diseases | Corporate Officer/Principal | - |
Anciens postes connus de Kaouthar Lbiati
| Sociétés | Poste | Fin |
|---|---|---|
| HEPION PHARMACEUTICALS, INC. | Directeur Général | 16/03/2026 |
| IMMUNE PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Steba Biotech SA
 Steba Biotech SA Miscellaneous Commercial ServicesCommercial Services Operates as biotechnology company, which develops therapy to fight cancer | Corporate Officer/Principal | - |
Formation de Kaouthar Lbiati
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
11
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Hepion Pharmaceuticals, Inc.
 Hepion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drug therapy for treatment of chronic liver diseases | Health Technology |
Theralase Technologies, Inc.
 Theralase Technologies, Inc. Medical SpecialtiesHealth Technology Designs, develops and manufactures super-pulsed, cold laser technology and equipment | Health Technology |
London School of Economics & Political Science
 London School of Economics & Political Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ESSEC Business School
 ESSEC Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mohammed V University
 Mohammed V University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immune Pharmaceuticals, Inc.
 Immune Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of cancer and pain | Health Technology |
Steba Biotech SA
Steba Biotech SA Miscellaneous Commercial ServicesCommercial Services Operates as biotechnology company, which develops therapy to fight cancer | Commercial Services |
Cytovia Therapeutics, Inc.
Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Develops immunotherapies for cancer and infectious diseases | Health Technology |
